UT College of Pharmacy and Pharmaceutical Sciences News

Posts Tagged ‘The University of Toledo College of Pharmacy and Pharmaceutical Sciences’

UT Student Selected for Scholars Program

UT Pharmacy student Angela Simon was selected for the PQA-CVS Health Foundation Scholars Program. The program’s goal is to “support and recognize student excellence in projects centered on quality-related initiatives; encourage, promote, and improve education surrounding quality measures and value-based models of care; and foster student interest and engagement in the development of quality-related initiatives.”

Angela receives a $1,250 scholarship to Scholars to attend the PQA Leadership Summit in November 2017, along with an invitation to present the results of her project at the PQA Annual Meeting in May. Angela’s research will focus on factors that influence the intent of community pharmacists to provide medication therapy management. Her thesis advisors, Dr. Sharrel Pinto, and committee members, Dr. Cindy Puffer and Dr. Sadik Khuder, will advise her during this project.

Source: http://pqaalliance.org/academic/scholars.asp

State of the College 2016

Since 2013, Dean Early has delivered a State of the College address each fall at the Honors and Awards Convocation, a ceremony that recognizes student achievement and honors the donors and friends of the college. This year’s address focused on the return on investment seen by donors, new academic programs, the uniqueness of the college’s programs, and research.

Slideshow of presentation

Collaborating for a Cure

Dr. Tiwari; Mary Kay Verhoff, director of the Women’s Wellness Center and Breast Cancer Coalition Awareness coordinator for St. Rita’s Medical Center, in Lima Ohio; and Angelique Nyinawabera, graduate student in Department of Pharmacology and Experimental Therapeutics.

Dr. Tiwari, Mary Kay Verhoff, director of the Women’s Wellness Center and Breast Cancer Coalition Awareness coordinator for St. Rita’s Medical Center, in Lima Ohio, and Angelique Nyinawabera

Dr. Amit K. Tiwari, assistant professor in the Department of Pharmacology and Experimental Therapeutics, was invited to present at the First Annual Breast Cancer Summit at St. Rita’s Medical Center in Lima, Ohio. The purpose of the summit was to improve breast cancer outcomes through early detection, survivorship support and health promotion, and participants included breast cancer survivors, primary health care personnel like nurses, technicians, physicians and pharmacists, and students and community members.

Triple-negative breast cancer (TNBC), which lacks three key cell surface receptors (ER,PR and HER2), is highly heterogeneous, aggressive, invasive, and metastatic. It recurs more frequently and offers a worse prognosis than other forms of breast cancer. TNBC also presents the highest health disparity, since it is three times more common among African-American women than among Caucasian women. Current chemotherapy, including targeted therapies, has limited value in the treatment of TNBC.

Dr. Tiwari discussed and provided information on current therapy options (taxanes, anthracyclines, PARP, platinums and other combinations) and future individualized therapy options for TNBC.

Angelique Nyinawabera, a graduate student in Department of Pharmacology and Experimental Therapeutics who is mentored by Dr. Tiwari, also attended the conference. Angelique’s research efforts are dedicated towards bridging the health disparity gap experienced by African-American women. Her dissertation focuses on targeting highly dysregulated mitochondrial genes to develop novel TNBC therapeutics.

This summit, which was designated for a maximum of 2.5 AMA PRA Category 1 Credits™, was sponsored by St. Rita’s Center for Continuing Education, which is accredited by the Ohio State Medical Association to provide continuing medical education for physicians. Dr. Tiwari believes this summit, and other similar programs that promote collaboration and discussion among patients, researchers and health care professionals, can improve care and outcomes tremendously, leading us toward a cure.

Student Society of Health-system Pharmacists receives national recognition

The University of Toledo chapter of Student Society of Health-system Pharmacists achieved recognition from the American Society of Health-system Pharmacists (ASHP) for 2016-17 academic year. The honor includes a certificate of recognition, a complimentary ASHP publication, awards for the incoming and outgoing student officers, and a complimentary student registration to the 2016 Midyear Clinical Meeting and 2017 Summer Meetings.

José Treviño displays his artistic talent in the college

Jose Trevino and Rocky the Pharmacist

Jose Trevino and Rocky the Pharmacist

Most students in the College of Pharmacy and Pharmaceutical Sciences know José Treviño for his role as Director of Transfer Services and Recruitment for the college’s Office of Student Affairs, but many don’t know how skillful he is with a chainsaw. About 15 years ago, he was inspired to create wood carvings by a friend who carved totem poles from large pieces of driftwood from Lake Erie.  Wood carving is a way for José to connect with his Latino culture, and he often creates pieces symbolic of his heritage. Many of these adorn his home.

After carving his elaborate creations, José sands them down with a grinder and adds paint or stain, always careful that the beautiful grains in the wood are visible. For José , this pastime provides focus and a way to escape from the stresses of life.

“The tools I use drown out the sounds of what is going on all around me so I can focus on what I am doing.  I also enjoy seeing these pieces begin to take shape,” José said.

While José generally creates these pieces for his family’s enjoyment, some have been seen in the corridors of the Frederic and Mary Wolfe Center and have been featured at art exhibits and even The Toledo art Museum of Art.

Recent changes in recruitment efforts in the College of Pharmacy and Pharmaceutical Sciences

Mary F. Powers, BSPharm ’82, PhD ’96
Associate dean for Main Campus Student Affairs and Enrollment Management

In January 2015, Dean Early appointed Dr. Mary Powers as associate dean for Main Campus Student Affairs and Enrollment Management, with oversight of the college’s undergraduate recruitment into the Doctor of Pharmacy (PharmD) and Bachelor of Science in Pharmaceutical Sciences (BSPS) programs as part of the duties of this post. Specifically, the Student Affairs team has been working on strategies to address consistent declines in enrollments across all of academic pharmacy that have occurred since 2009. The enrollment management team within the college has implemented numerous initiatives and enhancements to our recruitment efforts to increase the numbers of excellent students we attract.

In spring 2015, the college hired a new enrollment management specialist, Angela Lopez, who had experience in UT’s Office of Admissions. Daniel Fackelman, an alumnus of the BSPS program, was hired in fall 2015 to focus on recruitment for the BSPS majors. Together, Angela and Daniel travel throughout the region to share information about our programs, facilities and faculty. Our UT Experience Days, during which prospective students visit the campus and meet faculty and students, now include a faculty lecture series that allows students to learn about the research occurring in our college and the ways this research affects patient care and the pharmaceutical industry.

Pharmacy Camp continues to be a great avenue for introducing students to pharmacy and to our college. José Trevino, director of transfer services and recruitment, added to his duties the role of Pharmacy Camp director. In addition to the traditional Walgreen’s Pharmacy Pharmacy Practice Camp that focuses on pharmacy practice and the profession of pharmacy, the college has added a camp focused specifically on the pharmaceutical sciences. The Shimadzu Pharmaceutical Science Camp is supported by Amway.

Using web technology, we added Echo Targeting advertising as a way to recruit students into the PharmD program and into the cosmetic science and pre-med majors (medicinal chemistry and pharmacology) of the BSPS programs. By enhancing relationships with community colleges and continuing the fast track program for students in the Toledo Early College High School, we are maintaining a pipeline to the BSPS degree.

The college has multiple pathways to apply to the professional division for transfer students and applicants who have already earned a degree. Literature was developed to explain these pathways to our students and facilitate their successful application to the professional division.
The Pharmacy Ambassadors, a student organization closely tied to recruitment and the student experience, has been instrumental in providing campus tours during prospective student visits and hosting high school students who want to shadow, or immerse themselves in the pharmacy student experience for a defined period of time. The office developed a training manual for Pharmacy Ambassadors and showed appreciation for this enthusiastic group with letters of recognition from the associate dean and a cookout for the ambassadors. As an extension to the Pharmacy Ambassadors, we also formed Pharmacy Ambassadors Leadership Society (PALS), a volunteer network of recruitment ambassadors composed of faculty, staff, alumni, and parents of current students.

With a focus on the areas of the state that are most fruitful for recruitment to our college, the Office of Student Affairs developed purposeful recruitment strategies in northeast Ohio and developed recruitment literature focused on students in the greater Cleveland area. The college also established relationships with the Ohio HOSA Future Health Professional high school student organization. The college’s Office of Student Affairs also engaged UT’s recruiters from the Office of Admissions to highlight the recruitment needs of our academic programs.

The results of these efforts to enhance recruitment are anticipated to begin with modest enrollment increases, starting with the freshman class in fall 2017. Thereafter, benefits to our enrollments are anticipated to be seen annually.

Walgreens Pharmacy Camp jump-starts careers

Pharmacy Summer Camp, sponsored by Walgreens, is more than just a fun way to spend a few nights on a college campus; it is also an on-ramp to a career in pharmacy.

At The University of Toledo, three faculty members in the College of Pharmacy and Pharmaceutical Sciences can attest to the power of Pharmacy Summer Camp. Drs. Anthony Pattin, Michelle Schroeder and Michelle Serres, faculty members in the Department of Pharmacy Practice, all came to the college in the early 2000s as rising high school juniors, eager to learn about pharmacy.  Their career paths demonstrate a love for the profession of pharmacy that was initiated during the camp experience.

Dr. Anthony Pattin

As a Toledo native, Dr. Anthony Pattin had the opportunity to attend pharmacy camp during the summer of 2002. Helping an elderly neighbor organize her medications sparked Dr. Pattin’s interest in becoming a practitioner, and a subsequent job at a pharmacy sealed the deal for him. Even then, he enjoyed patient interactions and counseling.

Today, Dr. Pattin is an alumnus of The University of Toledo, having completed his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from The University of Toledo in 2007 and 2009, respectively. He completed a PGY-1 community pharmacy residency at The University of Toledo in 2010 and began his career as a clinical assistant professor at the Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences. Last year, Dr. Pattin accepted a tenure-track assistant professor position at The University of Toledo College of Pharmacy and Pharmaceutical Sciences.

Dr. Pattin’s research and pharmacy practice interests include expansion of community pharmacists’ services, including vaccinations, medication therapy management, and medication adherence monitoring. The first African-American PharmD faculty member in the history of The College of Pharmacy and Pharmaceutical Sciences, Dr. Pattin mentions how the experiences at pharmacy camp inspired him to pursue pharmacy “full steam ahead”. He is thankful for Walgreens and their continued sponsorship of Pharmacy Summer Camp.

Dr. Michelle Schroeder

Dr. Michelle Schroeder participated in the 2004 session of Pharmacy Summer Camp. She earned her Doctor of Pharmacy Degree from Ohio Northern University in 2011 and completed the community pharmacy residency program at The University of Toledo in 2012. Dr. Schroeder joined the faculty in 2012 as a clinical assistant professor of Pharmacy Practice and was a part-time Kroger Pharmacist for four years. Her primary practice site is with the diabetes education program through The University of Toledo Center for Diabetes Self-Management, Education, and Training. She is involved with the program as the program coordinator and as a certified diabetes educator (CDE).

In addition to working with the diabetes education program, Dr. Schroeder is also involved in experiential teaching of ambulatory care pharmacy for APPE’s, IPPE’s and pharmacy residents. She continues to be involved with the Pharmacy Summer Camp, leading a glucose monitoring activity in which the students learn about glucose meters and participate in a hands-on exercise checking their own blood glucose.

Dr. Michelle Serres

Dr. Michelle Serres is a clinical assistant professor of Pharmacy Practice and Director of Introductory Pharmacy Practice Experiences (IPPEs) at The University of Toledo College of Pharmacy and Pharmaceutical Sciences. Dr. Serres completed the Walgreens-sponsored Pharmacy Summer Camp in the summer of 2003 and went on to earn her Bachelor of Science in Pharmaceutical Sciences in 2008 and Doctor of Pharmacy in 2010 from The University of Toledo. She completed a post-graduate year-one (PGY1) pharmacy residency in primary care with the W. W. Knight Family Medicine Program at The Toledo Hospital and joined the faculty in 2011. Dr. Serres earned Board Certification of Advanced Diabetes Management (BC-ADM) in December 2011, received Board Certification in Ambulatory Care Pharmacy in 2012, and is a certified insulin pump educator.

Currently the director of Introductory Pharmacy Practice Experiences, where she coordinates and manages P1-P3 student pharmacy and community experiences, Dr. Serres works with preceptors, students and sites to create and manage college relationships. She serves on and leads several college committees as a representative for experiential education, including the Admissions Committee, the Academic Performance Committee and is co-chair of the Professional Conduct Committee. In addition, she implemented, and was the former director of, The University of Toledo Diabetes Education, Self-Management and Training Program, accredited by AADE, based out of the Department of Endocrinology at The University of Toledo Medical Center. Dr. Serres now serves in clinical practice at the Center for Health Services, where she works with and manages patients with Type 1 and Type 2 diabetes and other chronic disease states in an outpatient primary care setting. Dr. Serres is also the president elect of Toledo Academy of Pharmacy (TAP).

The careers of these faculty members grew from their own motivation to pursue the profession, paired with the generous and ongoing support of Walgreens at the start of their career exploration. The philanthropy of Walgreens has included  direct support of Pharmacy Summer Camp for fifteen years, along with generous diversity grants.

Dean Early selected as NPhA Fellow

NPhA welcomed their inaugural class of NPhA Fellows.  The distinguished group included Johnnie L. Early, II PhD, RPh; H.W. “Ted” Matthews, PhD, RPh; Terrence V. Burroughs, MBA, CMTM, RPh; Barry Bleidt, PhD, Pharm D, RPh, and Marcellus Grace, PhD, RPh.  The NPhA Fellows Recognition Program (FNPhA) was created to grant recognition and promote awareness of pharmacists who have a record of outstanding service to the profession through contributions to NPhA. These members have sustained, continuous membership of at least ten years and have demonstrated excellence in serving the medically undeserved.

Dr. Early was a charter member of Student National Pharmaceutical Association, the student affiliate organization of National Pharmaceutical Association, and is the first charter member to be honored in this way.

International Conference on Emerging Healthcare Materials and Advancement in Toxicology 2016

Emerging HealthCare Materials & Advancement in Toxicology, 1-3 September 2016, Radisson Hotel, Health Sciences Campus, The University of Toledo, Toledo, Ohio

ECAT Conference participants

ECAT Conference participants

An International Conference on Emerging Healthcare Materials and Advancement in Toxicology 2016 was held at Radisson Hotel, The University of Toledo Health Science Campus, Toledo, Ohio, USA, from September 1 – 3, 2016. The conference was organized by Dr. Zahoor A. Shah and Dr. Frederick E. Williams from College of Pharmacy and Pharmaceutical Sciences in collaboration with Dr. Iqbal Ahmad, The University of Manchester, UK.

This conference was the first of its kind focused on emerging healthcare materials and advancements in toxicology. The city of Toledo was selected due to its proximity to big cities like Detroit, Cleveland, Columbus and Ann Arbor. The main focus of this conference was to bring researchers from academia, industry, government and non-governmental organizations onto one platform to discuss the emerging research on nanotechnology and healthcare medicine and its effects on human health. This opportunity facilitated new collaborations and networking benefits to researchers working and studying hard to make healthy use of nanotechnology. Imminent scientists/researchers across the country participated in the conference and the key note/distinguished and invited speakers list is below.

OPENING PLENARY LECTURE: ROBERT L. TANGUAY, Distinguished Professor of Molecular Toxicology Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR.

TITLE: Rapid In Vivo Assessment of the Nano/Bio Interface to Help Develop Safer Nanomaterials.

DISTINGUISHED LECTURE: MARK BANASZAK HOLL, Professor of Chemistry; Director of Macromolecular Science and Engineering, College of Engineering, University of Michigan, An Arbor, MI

TITLE: Fluorescent Materials For Biological Imaging.



JOHN P. WISE, Professor of Pharmacology and Toxicology, School of Medicine, University of Louisville. Louisville, KY

TITLE:  Of Whales and Men:  Lessons Learned about Global Pollution from Great Whales.

MICHAEL CARVAN, Professor, School of Freshwater Sciences, University of Wisconsin, Milwaukee, IL

TITLE: Developmental Methylmercury Exposure Leads to Transgenerational Adult Neurobehavioral Defects—Using Zebrafish to Understand Mechanism.

YANG H. YUN, Associate Professor of Biomedical Engineering, College of Engineering, The University of Akron, Akron, OH

TITLE: The Application of L-Tyrosine Polyphosphate in Nanomedicine.

MOHAMMED O. ALJAHDALI, Professor of Ecological Physiology, King Abdulaziz University Rabigh, Saudi Arabia.

TITLE: Sesamin Ameliorates STZ Induced Free Radical Mediated Oxidative Stress in Diabetic Retina.

ANDREW P. AULT, Assistant Professor of Environmental Health Sciences and Chemistry, School of Public Health, University of Michigan, An Arbor, MI

TITLE: Rapid Size and pH-Dependent Modification of Silver Nanoparticles in Simulated Gastrointestinal System

KATSUHISA KUROGI, Assistant Professor, University of Miyazaki, Japan

TITLE: Investigation of the Metabolism of Steroids-Related Compounds Through Sulfation Using the Zebrafish.

TARIQ HAMID, Assistant Professor, School, Cardiovascular Disease Center, School of Medicine, University of Alabama, Birmingham, AL

TITLE: Anticancer Drug Imatinib, Stem Cells and Myocardial Regeneration.

JERRY NESAMONY, Associate Professor of Pharmaceutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH

TITLE: Exploring Multiple Strategies to Develop Nanostructured Systems For Use in Drug Delivery.

SCOTT HALL, Assistant Professor, Assistant Professor of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH


Soligenix Appoints Alumna Karen Krumeich, BSP ’77, as Chief Financial Officer

PRINCETON, N.J., June 20, 2016 /PRNewswire/ — Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has appointed Karen Krumeich, as its Senior Vice President and Chief Financial Officer.  Ms. Krumeich has over 25 years of diverse experience in the financial and strategic management of emerging growth life science companies. She has a proven track record and expertise in corporate financial operations, equity financings, and business development, including partnerships, mergers and acquisitions.

Most recently, Ms. Krumeich served as a consultant providing finance, investor relations, and business development services to the Company and other healthcare companies. Previously, she worked as Vice President and Chief Financial Officer for several development-stage life science companies, including Cerecor, Inc. and Mela Sciences, Inc. where she was responsible for equity financings, corporate administrative functions, and investor relations. In addition to these positions, Ms. Krumeich was a healthcare consultant partner with Tatum, LLC, a national consulting firm, specializing in their life science practice. Prior to these positions, she held positions of increasing responsibility with several healthcare companies, including Bristol-Myers Squibb Company where she was Director of Health Systems and as Vice President of Finance for a national pharmacy provider. Ms. Krumeich began her career as a pharmacist and transitioned into finance after successfully completing the CPA exam.

Ms. Krumeich earned a BS in Pharmacy from the University of Toledo, Ohio and completed her post graduate work in accounting and finance at Cleveland State University while pursuing her career as a pharmacist.

“We are delighted to welcome Karen to our team, as we leverage her extensive financial expertise in leading our strategic corporate programs,” stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix.  “As we continue to execute our growth strategy, we are clearly building momentum and the talent we are attracting is an absolute reflection of our solid progress to date.  Karen’s unique experiences in both science and finance will be instrumental to us as we advance our multiple late-stage development programs.”

Mr. Joseph Warusz, who has served as Vice President, Finance and Acting Chief Financial Officer since February 2012, will be retiring from the Company effective June 30, 2016. On behalf of the Company and its Board of Directors, we would like to thank Joe for his many contributions during the past five years.

About Soligenix, Inc.

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our BioTherapeutics business segment is developing SGX301 as a first-in-class photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma, proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation including pediatric Crohn’s disease (SGX203) and acute radiation enteritis (SGX201), and our novel innate defense regulator technology dusquetide (SGX942) for the treatment of oral mucositis.

Our Vaccines/BioDefense business segment includes active development programs for RiVax™, our ricin toxin vaccine candidate, OrbeShield®, our GI acute radiation syndrome therapeutic candidate and SGX943, our melioidosis therapeutic candidate. The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known as ThermoVax®.  Currently, this business segment is supported with up to $57 million in government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).

For further information regarding Soligenix, Inc., please visit the Company’s website at www.soligenix.com.